Skip to main content
. 2017 Aug 17;117(7):1079–1087. doi: 10.1038/bjc.2017.272

Table 3. HRs for CRC-specific mortality among patients with colorectal cancer by quintile of post-diagnosis dietary insulin index stratified by predictors of patient outcome.

    Dietary insulin index
 
      Quintile 2 Quintile 3 Quintile 4 Quintile 5  
Stratification covariate No. of patients Quintile 1 HR (95% CI)a HR (95% CI)a HR (95% CI)a HR (95% CI)a Pinteraction
Age at diagnosis, yearsb             0.56
 ⩽67 999 Referent 1.39 (0.84–2.29) 1.50 (0.91–2.47) 1.92 (1.16–3.17) 1.79 (1.04–3.07)  
 >67 1007 Referent 0.90 (0.49–1.67) 1.09 (0.61–1.96) 1.24 (0.71–2.18) 1.44 (0.82–2.54)  
Sex             1.00
 Female 1314 Referent 0.99 (0.62–1.58) 1.24 (0.78–1.95) 1.53 (0.97–2.42) 1.58 (0.98–2.54)  
 Male 692 Referent 1.70 (0.86–3.37) 1.50 (0.74–3.02) 1.73 (0.89–3.39) 1.81 (0.89–3.67)  
BMI, kg m−2             0.01
 <25.0 890 Referent 1.13 (0.69–1.85) 0.80 (0.47–1.35) 0.97 (0.57–1.63) 1.14 (0.67–1.93)  
 ⩾25.0 966 Referent 1.10 (0.55–2.22) 2.24 (1.21–4.14) 2.93 (1.59–5.40) 2.32 (1.21–4.46)  
Physical activity, MET-h per weekb             0.40
 ⩽10.2 917 Referent 1.47 (0.80–2.68) 1.84 (1.02–3.31) 2.28 (1.29–4.02) 2.37 (1.30–4.30)  
 >10.2 908 Referent 1.07 (0.57–2.00) 0.98 (0.53–1.82) 1.04 (0.55–1.97) 1.47 (0.79–2.72)  
Alcohol intake, g d−1b             0.38
 ⩽1.9 1011 Referent 0.76 (0.40–1.43) 0.88 (0.47–1.62) 1.09 (0.61–1.95) 1.01 (0.56–1.82)  
 >1.9 995 Referent 1.32 (0.82–2.13) 1.45 (0.90–2.33) 1.63 (0.99–2.69) 2.26 (1.34–3.81)  
Diagnosis periodb             0.82
 1976–1997 1056 Referent 1.30 (0.78–2.16) 1.28 (0.77–2.11) 2.02 (1.24–3.31) 1.60 (0.94–2.72)  
 1998–2010 950 Referent 0.99 (0.54–1.82) 1.53 (0.85–2.76) 0.96 (0.52–1.79) 1.72 (0.97–3.07)  
Time between diagnosis and dietary assessment, years             0.14
 0<2 1105 Referent 1.15 (0.72–1.83) 1.52 (0.96–2.43) 1.54 (0.98–2.43) 2.11 (1.33–3.37)  
 2–4 901 Referent 1.21 (0.61–2.41) 1.17 (0.61–2.24) 1.68 (0.86–3.27) 1.05 (0.51–2.18)  
Stage             1.00
 I/II 1204 Referent 1.44 (0.71–2.88) 1.83 (0.92–3.63) 2.12 (1.09–4.12) 1.63 (0.80–3.34)  
 III/IV 573 Referent 1.21 (0.73–2.00) 1.17 (0.71–1.92) 1.38 (0.83–2.29) 1.73 (1.05–2.83)  
Grade of tumour differentiation             0.17
 Well/moderate 1416 Referent 1.15 (0.69–1.92) 1.63 (1.01–2.63) 1.81 (1.12–2.92) 2.05 (1.24–3.39)  
 Poor 265 Referent 1.62 (0.76–3.42) 1.09 (0.51–2.37) 0.97 (0.42–2.25) 1.09 (0.43–2.74)  
Location of primary tumour             0.75
 Colon 1467 Referent 1.33 (0.82–2.17) 1.56 (0.98–2.50) 1.82 (1.14–2.90) 1.79 (1.09–2.92)  
 Rectum 444 Referent 0.87 (0.44–1.73) 0.88 (0.42–1.80) 1.14 (0.57–2.27) 1.35 (0.67–2.72)  

Abbreviations: BMI=body mass index; CI=confidence interval; CRC=colorectal cancer; HR=hazard ratio; MET=metabolic equivalent.

a

Adjusted for age at diagnosis (continuous), sex, race (White, Black, other, unknown), smoking status (never, past, current, unknown), body mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9, ⩾35.0 kg m−2, or unknown), physical activity (quintiles or unknown), alcohol intake (0, 0.1–4.9, 5.0–14.9, ⩾15.0 g d−2), cancer stage (I–IV or unknown), grade of tumour differentiation (well, moderate, poor, unknown), location of primary tumour (proximal, distal, rectum, unknown) and year of diagnosis (continuous), excluding the stratification covariate.

b

Cutpoints chosen based on median values.